Glioblastoma Multiforme Therapeutics Market
1 Introduction to Research & Analysis Reports
1.1 Glioblastoma Multiforme (GBM) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glioblastoma Multiforme (GBM) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glioblastoma Multiforme (GBM) Therapeutics Overall Market Size
2.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size: 2021 VS 2028
2.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Glioblastoma Multiforme (GBM) Therapeutics Players in Global Market
3.2 Top Global Glioblastoma Multiforme (GBM) Therapeutics Companies Ranked by Revenue
3.3 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Glioblastoma Multiforme (GBM) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glioblastoma Multiforme (GBM) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glioblastoma Multiforme (GBM) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Glioblastoma Multiforme (GBM) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Glioblastoma Multiforme (GBM) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Markets, 2021 & 2028
4.1.2 ChemOthersapy
4.1.3 Targeted Drug Therapy
4.1.4 Radiation Therapy
4.2 By Type - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2028
6.3.2 US Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.3.3 Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.3.4 Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2028
6.4.2 Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4.3 France Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4.4 U.K. Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4.5 Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4.6 Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.4.8 Benelux Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2028
6.5.2 China Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.5.3 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.5.4 South Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.5.6 India Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2028
6.6.2 Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.6.3 Argentina Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2028
6.7.2 Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.7.3 Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
6.7.5 UAE Glioblastoma Multiforme (GBM) Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.1.4 Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.2.4 Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Arbor Pharmaceuticals
7.3.1 Arbor Pharmaceuticals Corporate Summary
7.3.2 Arbor Pharmaceuticals Business Overview
7.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.3.4 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Arbor Pharmaceuticals Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.4.4 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.5.4 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.5.5 AbbVie Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.6.4 Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.7.4 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Sun Pharmaceuticals
7.8.1 Sun Pharmaceuticals Corporate Summary
7.8.2 Sun Pharmaceuticals Business Overview
7.8.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.8.4 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Sun Pharmaceuticals Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.9.4 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Key News
7.10 Emcure Pharmaceuticals
7.10.1 Emcure Pharmaceuticals Corporate Summary
7.10.2 Emcure Pharmaceuticals Business Overview
7.10.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Major Product Offerings
7.10.4 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Emcure Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Glioblastoma Multiforme (GBM) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Glioblastoma Multiforme (GBM) Therapeutics Market Drivers in Global Market
Table 3. Glioblastoma Multiforme (GBM) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Glioblastoma Multiforme (GBM) Therapeutics in Global Market
Table 5. Top Glioblastoma Multiforme (GBM) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glioblastoma Multiforme (GBM) Therapeutics Product Type
Table 9. List of Global Tier 1 Glioblastoma Multiforme (GBM) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioblastoma Multiforme (GBM) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glioblastoma Multiforme (GBM) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 32. Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 35. Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Arbor Pharmaceuticals Corporate Summary
Table 37. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 38. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 41. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. AbbVie Corporate Summary
Table 43. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 44. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 47. Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 50. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Sun Pharmaceuticals Corporate Summary
Table 52. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 53. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 56. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Emcure Pharmaceuticals Corporate Summary
Table 58. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offerings
Table 59. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Glioblastoma Multiforme (GBM) Therapeutics Segment by Type in 2021
Figure 2. Glioblastoma Multiforme (GBM) Therapeutics Segment by Application in 2021
Figure 3. Global Glioblastoma Multiforme (GBM) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glioblastoma Multiforme (GBM) Therapeutics Revenue in 2021
Figure 8. By Type - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glioblastoma Multiforme (GBM) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
